NSMCX
Price
$26.01
Change
-$0.20 (-0.76%)
Updated
Aug 15 closing price
Net Assets
93.26M
VSCPX
Price
$340.19
Change
-$1.26 (-0.37%)
Updated
Aug 15 closing price
Net Assets
154.18B
Interact to see
Advertisement

NSMCX vs VSCPX

Header iconNSMCX vs VSCPX Comparison
Open Charts NSMCX vs VSCPXBanner chart's image
Nuveen Small/Mid-Cap Value C
Price$26.01
Change-$0.20 (-0.76%)
VolumeN/A
Net Assets93.26M
Vanguard Small Cap Index InstlPlus
Price$340.19
Change-$1.26 (-0.37%)
VolumeN/A
Net Assets154.18B
NSMCX vs VSCPX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
NSMCX vs. VSCPX commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NSMCX is a Buy and VSCPX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCPX has more cash in the bank: 154B vs. NSMCX (93.3M). VSCPX pays higher dividends than NSMCX: VSCPX (1.39) vs NSMCX (0.38). NSMCX was incepted earlier than VSCPX: NSMCX (19 years) vs VSCPX (15 years). NSMCX (2.17) is less costly to investors than VSCPX (0.03). NSMCX is a more actively managed with annual turnover of: 81.00 vs. VSCPX (13.00). NSMCX has a lower initial minimum investment than VSCPX: NSMCX (2500) vs VSCPX (100000000). VSCPX annual gain was more profitable for investors over the last year : 9.18 vs. NSMCX (-4.60). VSCPX return over 5 years is better than : 57.76 vs. NSMCX (40.35).
NSMCXVSCPXNSMCX / VSCPX
Total Expense Ratio2.060.036,867%
Annual Report Gross Expense Ratio2.170.037,233%
Fund Existence19 years15 years-
Gain YTD2.6852.528106%
Front LoadN/AN/A-
Min. Initial Investment25001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets93.3M154B0%
Annual Yield % from dividends0.381.3927%
Returns for 1 year-4.609.18-50%
Returns for 3 years12.2520.5060%
Returns for 5 years40.3557.7670%
Returns for 10 years1.82113.192%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KPTI5.921.27
+27.31%
Karyopharm Therapeutics Inc.
EWTX14.150.22
+1.58%
Edgewise Therapeutics
RYAN59.12-0.39
-0.66%
Ryan Specialty Holdings
MBINM25.19-0.18
-0.72%
Merchants Bancorp
ALT3.63-0.05
-1.36%
Altimmune